Rejuvenation of the aging T cell compartment

Current Opinion in Immunology

Volumn 21, Issue 4, 2009, Pages 454-459

  Holland, Amanda M ^a,b   van den Brink, Marcel RM ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GOSERELIN; GROWTH HORMONE; INTERLEUKIN 12; INTERLEUKIN 15; KERATINOCYTE GROWTH FACTOR; LEUPRORELIN; RECOMBINANT INTERLEUKIN 7; SEX HORMONE; SOMATOMEDIN C;

AGING; CANCER SUSCEPTIBILITY; CASTRATION; CELL EXPANSION; CELL REGENERATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG MECHANISM; ELDERLY CARE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFECTION SENSITIVITY; INFLAMMATION; LYMPHOCYTOPOIESIS; MELANOMA; MUCOSA INFLAMMATION; NONHUMAN; REVIEW; SARCOMA; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS FUNCTION;

AGING; ANIMALS; BONE MARROW TRANSPLANTATION; CYTOKINES; FIBROBLAST GROWTH FACTOR 7; GONADAL STEROID HORMONES; GROWTH HORMONE; GUIDED TISSUE REGENERATION; HUMANS; IMMUNE TOLERANCE; INSULIN-LIKE GROWTH FACTOR I; MICE; REJUVENATION; T-LYMPHOCYTES;

EID: 68149148867     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.06.002     Document Type: Review

References (67)

1. Akbar A.N., and Fletcher J.M. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 17 (2005) 480-485
2. Colonna-Romano G., Akbar A.N., Aquino A., Bulati M., Candore G., Lio D., Ammatuna P., Fletcher J.M., Caruso C., and Pawelec G. Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol 42 (2007) 995-1002
3. Appelbaum F.R. Haematopoietic cell transplantation as immunotherapy. Nature 411 (2001) 385-389
4. Greenstein B.D., Fitzpatrick F.T., Adcock I.M., Kendall M.D., and Wheeler M.J. Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J Endocrinol 110 (1986) 417-422
5. Greenstein B.D., Fitzpatrick F.T., Kendall M.D., and Wheeler M.J. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 112 (1987) 345-350
6. Heng T.S., Goldberg G.L., Gray D.H., Sutherland J.S., Chidgey A.P., and Boyd R.L. Effects of castration on thymocyte development in two different models of thymic involution. J Immunol 175 (2005) 2982-2993
7. Sutherland J.S., Goldberg G.L., Hammett M.V., Uldrich A.P., Berzins S.P., Heng T.S., Blazar B.R., Millar J.L., Malin M.A., Chidgey A.P., et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 175 (2005) 2741-2753
8. Windmill K.F., and Lee V.W. Effects of castration on the lymphocytes of the thymus, spleen and lymph nodes. Tissue Cell 30 (1998) 104-111
9. Windmill K.F., Meade B.J., and Lee V.W. Effect of prepubertal gonadectomy and sex steroid treatment on the growth and lymphocyte populations of the rat thymus. Reprod Fertil Dev 5 (1993) 73-81
10. Goldberg G.L., Alpdogan O., Muriglan S.J., Hammett M.V., Milton M.K., Eng J.M., Hubbard V.M., Kochman A., Willis L.M., Greenberg A.S., et al. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 178 (2007) 7473-7484
11. Goldberg G.L., Sutherland J.S., Hammet M.V., Milton M.K., Heng T.S., Chidgey A.P., and Boyd R.L. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation 80 (2005) 1604-1613
12. Goldberg G.L., King C.G., Nejat R.A., Suh D.Y., Smith O.M., Bretz J.C., Samstein R.M., Dudakov J.A., Chidgey A.P., Chen-Kiang S., et al. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol 182 (2009) 5846-5854
13. Sutherland J.S., Spyroglou L., Muirhead J.L., Heng T.S., Prieto-Hinojosa A., Prince H.M., Chidgey A.P., Schwarer A.P., and Boyd R.L. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 14 (2008) 1138-1149. This study demonstrates that the LHRH agonist goserelin significantly improves T cell reconstitution in human autologous and allogeneic transplantation patients, and increases disease-free survival in autologous recipients.
14. Finch P.W., and Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 91 (2004) 69-136
15. Erickson M., Morkowski S., Lehar S., Gillard G., Beers C., Dooley J., Rubin J.S., Rudensky A., and Farr A.G. Regulation of thymic epithelium by keratinocyte growth factor. Blood 100 (2002) 3269-3278
16. Gray D.H., Tull D., Ueno T., Seach N., Classon B.J., Chidgey A., McConville M.J., and Boyd R.L. A unique thymic fibroblast population revealed by the monoclonal antibody MTS-15. J Immunol 178 (2007) 4956-4965
17. Finch P.W., Cunha G.R., Rubin J.S., Wong J., and Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 203 (1995) 223-240
18. Goldberg G.L., Zakrzewski J.L., Perales M.A., and van den Brink M.R. Clinical strategies to enhance T cell reconstitution. Semin Immunol 19 (2007) 289-296
19. Alpdogan O., Hubbard V.M., Smith O.M., Patel N., Lu S., Goldberg G.L., Gray D.H., Feinman J., Kochman A.A., Eng J.M., et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107 (2006) 2453-2460
20. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., and Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99 (2002) 4592-4600
21. Rossi S., Blazar B.R., Farrell C.L., Danilenko D.M., Lacey D.L., Weinberg K.I., Krenger W., and Hollander G.A. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100 (2002) 682-691
22. Jenq R.R., King C.G., Volk C., Suh D., Smith O.M., Rao U., Yim N., Holland A.M., Lu S.X., Zakrzewski J.L., et al. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses following murine allogeneic bone marrow transplantation. Blood (2008). This study demonstrates that KGF can be used as a vaccine adjuvant to enhance tumor-killing and overall survival in tumor-bearing murine recipients of allogeneic BMT. These findings are promising for elderly patients who typically respond poorly to vaccination.
23. Seggewiss R., Lore K., Guenaga F.J., Pittaluga S., Mattapallil J., Chow C.K., Koup R.A., Camphausen K., Nason M.C., Meier-Schellersheim M., et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 110 (2007) 441-449. Using a nonhuman primate model, the authors demonstrate that pretransplant or peritransplant KGF treatment resulted in maintenance of thymic architecture and enhanced T cell numbers in autologous recipients. This study supports the findings in small animals that FDA-approved KGF may improve T cell reconstitution in humans undergoing HSCT or age-related thymic atrophy.
24. Kelly R.M., Highfill S.L., Panoskaltsis-Mortari A., Taylor P.A., Boyd R.L., Hollander G.A., and Blazar B.R. Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 111 (2008) 5734-5744. The authors combine KGF administration with sex steroid blockade in a murine BMT model with additive benefits on T cell reconstitution.
25. Hattori N., Shimatsu A., Sugita M., Kumagai S., and Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem Biophys Res Commun 168 (1990) 396-401
26. Varma S., Sabharwal P., Sheridan J.F., and Malarkey W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J Clin Endocrinol Metab 76 (1993) 49-53
27. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., and Blalock J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2 (1988) 2812-2818
28. Weigent D.A., and Blalock J.E. Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol 29 (1990) 1-13
29. Bresson J.L., Jeay S., Gagnerault M.C., Kayser C., Beressi N., Wu Z., Kinet S., Dardenne M., and Postel-Vinay M.C. Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein. Endocrinology 140 (1999) 3203-3209
30. Dardenne M., Mello-Coelho V., Gagnerault M.C., and Postel-Vinay M.C. Growth hormone receptors and immunocompetent cells. Ann N Y Acad Sci 840 (1998) 510-517
31. de Mello-Coelho V., Gagnerault M.C., Souberbielle J.C., Strasburger C.J., Savino W., Dardenne M., and Postel-Vinay M.C. Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 139 (1998) 3837-3842
32. Gagnerault M.C., Postel-Vinay M.C., and Dardenne M. Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry. Endocrinology 137 (1996) 1719-1726
33. Welniak L.A., Sun R., and Murphy W.J. The role of growth hormone in T-cell development and reconstitution. J Leukoc Biol 71 (2002) 381-387
34. Alpdogan O., Muriglan S.J., Kappel B.J., Doubrovina E., Schmaltz C., Schiro R., Eng J.M., Greenberg A.S., Willis L.M., Rotolo J.A., et al. Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation 75 (2003) 1977-1983
35. Kooijman R., Willems M., De Haas C.J., Rijkers G.T., Schuurmans A.L., Van Buul-Offers S.C., Heijnen C.J., and Zegers B.J. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131 (1992) 2244-2250
36. Stuart C.A., Meehan R.T., Neale L.S., Cintron N.M., and Furlanetto R.W. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab 72 (1991) 1117-1122
37. Walsh P.T., and O'Connor R. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol 30 (2000) 1010-1018
38. Chen B.J., Cui X., Sempowski G.D., and Chao N.J. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol 31 (2003) 953-958
39. Tian Z.G., Woody M.A., Sun R., Welniak L.A., Raziuddin A., Funakoshi S., Tsarfaty G., Longo D.L., and Murphy W.J. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells 16 (1998) 193-199
40. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
41. Smith R.G., Jiang H., and Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol Metab 16 (2005) 436-442
42. Dixit V.D., and Taub D.D. Ghrelin and immunity: a young player in an old field. Exp Gerontol 40 (2005) 900-910
43. Dixit V.D., Yang H., Cooper-Jenkins A., Giri B.B., Patel K., and Taub D.D. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood (2009)
44. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., and Taub D.D. Ghrelin promotes thymopoiesis during aging. J Clin Invest 117 (2007) 2778-2790. The authors describe for the first time that ghrelin levels decrease in the aging thymus, and that administration of ghrelin improved thymus structure and thymopoiesis in 14-month-old mice.
45. Youm Y.H., Yang H., Sun Y., Smith R.G., Manley N.R., Vandanmagsar B., and Dixit V.D. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J Biol Chem 284 (2009) 7068-7077. This paper demonstrates that loss of ghrelin leads to a reduction in the number of TEC and an increase in the number of adipocytes in the thymus. These findings suggest a mechanism through which ghrelin directly mediates thymic function by shaping the thymic microenvironment.
46. Sakata T., Iwagami S., Tsuruta Y., Teraoka H., Tatsumi Y., Kita Y., Nishikawa S., Takai Y., and Fujiwara H. Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line. J Leukoc Biol 48 (1990) 205-212
47. Morrissey P.J., McKenna H., Widmer M.B., Braddy S., Voice R., Charrier K., Williams D.E., and Watson J.D. Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3-/CD4-/CD8-thymocytes: synergy with IL-7. Cell Immunol 157 (1994) 118-131
48. von Freeden-Jeffry U., Solvason N., Howard M., and Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7 (1997) 147-154
49. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4 (2003) 1191-1198
50. Li J., Huston G., and Swain S.L. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198 (2003) 1807-1815
51. Schluns K.S., Kieper W.C., Jameson S.C., and Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1 (2000) 426-432
52. Abdul-Hai A., Or R., Slavin S., Friedman G., Weiss L., Matsa D., and Ben-Yehuda A. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 24 (1996) 1416-1422
53. Alpdogan O., Muriglan S.J., Eng J.M., Willis L.M., Greenberg A.S., Kappel B.J., and van den Brink M.R. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112 (2003) 1095-1107
54. Alpdogan O., Schmaltz C., Muriglan S.J., Kappel B.J., Perales M.A., Rotolo J.A., Halm J.A., Rich B.E., and van den Brink M.R. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98 (2001) 2256-2265
55. Bolotin E., Smogorzewska M., Smith S., Widmer M., and Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88 (1996) 1887-1894
56. Mackall C.L., Fry T.J., Bare C., Morgan P., Galbraith A., and Gress R.E. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97 (2001) 1491-1497
57. Dorshkind K., Montecino-Rodriguez E., and Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 9 (2009) 57-62
58. Rosenberg S.A., Sportes C., Ahmadzadeh M., Fry T.J., Ngo L.T., Schwarz S.L., Stetler-Stevenson M., Morton K.E., Mavroukakis S.A., Morre M., et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 29 (2006) 313-319
59. Sportes C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., Fleisher T.A., Krumlauf M.C., Babb R.R., Chow C.K., et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205 (2008) 1701-1714. IL-7 administration to patients with nonhematologic, nonlymphoid cancers led to increased T cell production and function, with enhanced proportions of recent thymic emigrants and naïve T cells.
60. Levy Y., Lacabaratz C., Weiss L., Viard J.P., Goujard C., Lelievre J.D., Boue F., Molina J.M., Rouzioux C., Avettand-Fenoel V., et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 119 (2009) 997-1007. This study demonstrates that IL-7 administration to HIV-1-infected patients with profound T cell deficiency leads to increased T cell numbers and enhanced cytokine secretion in response to HIV antigens.
61. Alpdogan O., Eng J.M., Muriglan S.J., Willis L.M., Hubbard V.M., Tjoe K.H., Terwey T.H., Kochman A., and van den Brink M.R. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 105 (2005) 865-873
62. Katsanis E., Xu Z., Panoskaltsis-Mortari A., Weisdorf D.J., Widmer M.B., and Blazar B.R. IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice. Transplantation 62 (1996) 872-875
63. Diab A., Cohen A.D., Alpdogan O., and Perales M.A. IL-15: targeting CD8+ T cells for immunotherapy. Cytotherapy 7 (2005) 23-35
64. Klebanoff C.A., Finkelstein S.E., Surman D.R., Lichtman M.K., Gattinoni L., Theoret M.R., Grewal N., Spiess P.J., Antony P.A., Palmer D.C., et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A 101 (2004) 1969-1974
65. Rubinstein M.P., Kadima A.N., Salem M.L., Nguyen C.L., Gillanders W.E., and Cole D.J. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. J Immunol 169 (2002) 4928-4935
66. Li L., Hsu H.C., Stockard C.R., Yang P., Zhou J., Wu Q., Grizzle W.E., and Mountz J.D. IL-12 inhibits thymic involution by enhancing IL-7- and IL-2-induced thymocyte proliferation. J Immunol 172 (2004) 2909-2916
67. Chen J., Wang J., Li J., Wu Q., Chu Lim F., Yang P., Hsu H.C., Curiel D.T., and Mountz J.D. Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession. Mol Ther 16 (2008) 1500-1506. The authors show that the administration of IL-12 to 18-month-old mice via an adenoviral vector results in enhanced cytotoxic T cell numbers, activity, and proliferation.